GSK

Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician
Fierce Pharma
Tue, 03/8/22 - 10:57 pm
GSK
HIV
Cabenuva
supply chain
distribution
GSK chief Emma Walmsley made $10.8M last year, lagging far behind fellow Big Pharma CEOs
Endpoints
Mon, 03/7/22 - 10:48 pm
GSK
Pharma CEOs
Emma Walmsley
executive pay
Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for sexual harassment
Fierce Pharma
Sun, 03/6/22 - 11:15 pm
GSK
Moncef Slaoui
sexual harassment
Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag
Fierce Biotech
Wed, 03/2/22 - 12:16 pm
Pfizer
GSK
vaccines
RSV
PF-06482077
FDA
breakthrough status
GlaxoSmithKline consumer business Haleon lays out game plan after July spinout
Endpoints
Mon, 02/28/22 - 11:39 pm
GSK
consumer healthcare
spinoffs
Haleon
GSK halts RSV vaccine trials in pregnant women after pause
Pharmaforum
Mon, 02/28/22 - 11:40 am
GSK
clinical trials
RSV
vaccines
pregnancy
Sanofi and GSK ready to seek authorization for COVID-19 vaccine
Biopharma Reporter
Wed, 02/23/22 - 10:40 am
Sanofi
GSK
vaccines
COVID-19
clinical trials
FDA
GlaxoSmithKline unveils Haleon, the new brand name for its outgoing consumer health unit
Fierce Pharma
Tue, 02/22/22 - 10:59 am
GSK
spinoffs
Haleon
consumer health
ASCO-GU – prostate cancer PARPS move to the front line
EP Vantage
Sun, 02/20/22 - 11:44 am
prostate cancer
ASCO-GU
PARP inhibitors
Lynparza
Zejula
Rubraca
Talzenna
biomarkers
AstraZeneca
Merck
GSK
JNJ
Clovis Oncology
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
Fierce Biotech
Fri, 02/18/22 - 10:37 am
GSK
Pfizer
RSV
vaccines
clinical trials
GSK launches trade secrets case against former employee, ordering data and property to be returned 'in one piece'
Fierce Pharma
Thu, 02/17/22 - 11:28 pm
GSK
trade secrets
legal
Tracking Gilead's 4 Big Stories and a Lawsuit in 2022
Motley Fool
Tue, 02/15/22 - 10:31 am
Gilead Sciences
GSK
legal
ViiV Healthcare
GSK joins a crowd of pharma companies restricting sales under federal program
Endpoints
Mon, 02/14/22 - 11:41 pm
GSK
340B
Medicare
Medicaid
Vaccines upstart Curevo has designs on blockbuster GSK franchise
Pharmaforum
Mon, 02/14/22 - 10:45 am
Curevo Vaccine
vaccines
GSK
CRV-101
Shingrix
shingles
With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda
Endpoints
Fri, 02/11/22 - 10:11 am
Biogen
Vir Biotechnology
GSK
Johanna Friedl-Naderer
Takeda
PhRMA
A small Seattle biotech wants to take on GlaxoSmithKline's emerging Shingrix blockbuster. RA Capital is on board
Endpoints
Thu, 02/10/22 - 10:27 am
GSK
Shingrix
FDA
RA Capital
Curevo Vaccine
GlaxoSmithKline's COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark
Fierce Pharma
Thu, 02/10/22 - 10:11 am
GSK
earnings
COVID-19
Vir Biotchnology
Galvani Bioelectronics implants first neurostimulator for splenic nerve stimulation in rheumatoid arthritis patient
MedCity News
Mon, 02/7/22 - 11:23 am
GSK
Verily
Galvani Bioelectronics
neurostimulation
rheumatoid arthritis
splenic nerve stimulation
GSK to get $1.25 bln to settle HIV drug patent row with Gilead
Reuters
Wed, 02/2/22 - 11:01 am
GSK
Gilead Sciences
HIV
Biktarvy
patents
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
Motley Fool
Fri, 01/28/22 - 10:20 am
GSK
Unilever
M&A
consumer health

Pages